BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17168873)

  • 1. A pilot study evaluating the efficacy of topically applied niacin derivatives for treatment of female pattern alopecia.
    Draelos ZD; Jacobson EL; Kim H; Kim M; Jacobson MK
    J Cosmet Dermatol; 2005 Dec; 4(4):258-61. PubMed ID: 17168873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
    J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of female pattern hair loss with oral antiandrogens.
    Sinclair R; Wewerinke M; Jolley D
    Br J Dermatol; 2005 Mar; 152(3):466-73. PubMed ID: 15787815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
    Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
    Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
    J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients.
    Kaufman KD; Girman CJ; Round EM; Johnson-Levonas AO; Shah AK; Rotonda J
    Eur J Dermatol; 2008; 18(4):407-11. PubMed ID: 18573713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial.
    Oura H; Iino M; Nakazawa Y; Tajima M; Ideta R; Nakaya Y; Arase S; Kishimoto J
    J Dermatol; 2008 Dec; 35(12):763-7. PubMed ID: 19239555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of minoxidil on hair growth in androgenic alopecia in women].
    Brzezińska-Wcisło L
    Pol Merkur Lekarski; 2002 Sep; 13(75):208-11. PubMed ID: 12474572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the sildenafil effect on alopecia areata in childhood: An open-pilot comparison study.
    Sarifakioglu E; Degim IT; Gorpelioglu C
    J Dermatolog Treat; 2006; 17(4):235-7. PubMed ID: 16971319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women.
    Hamzavi I; Tan E; Shapiro J; Lui H
    J Am Acad Dermatol; 2007 Jul; 57(1):54-9. PubMed ID: 17270315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hair loss in women.
    Camacho-Martínez FM
    Semin Cutan Med Surg; 2009 Mar; 28(1):19-32. PubMed ID: 19341939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dutasteride improves male pattern hair loss in a randomized study in identical twins.
    Stough D
    J Cosmet Dermatol; 2007 Mar; 6(1):9-13. PubMed ID: 17348989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness and safety of topical PhotoActif phosphatidylcholine-based anti-cellulite gel and LED (red and near-infrared) light on Grade II-III thigh cellulite: a randomized, double-blinded study.
    Sasaki GH; Oberg K; Tucker B; Gaston M
    J Cosmet Laser Ther; 2007 Jun; 9(2):87-96. PubMed ID: 17558758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
    Kaufman KD; Rotonda J; Shah AK; Meehan AG
    Eur J Dermatol; 2008; 18(4):400-6. PubMed ID: 18573712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Photographic documentation of the effectiveness of 1 mg. oral finasteride in treatment of androgenic alopecia in the man in routine general practice in Switzerland].
    Trüeb RM; Itin P;
    Praxis (Bern 1994); 2001 Nov; 90(48):2087-93. PubMed ID: 11770252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of female pattern hair loss: a study in a Turkish population.
    Aktan S; Akarsu S; Ilknur T; Demirtaşoğlu M; Ozkan S
    Eur J Dermatol; 2007; 17(4):321-4. PubMed ID: 17540640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.